Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
44.17
54.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Recordati Industria Chimica e Farmaceutica SpA
Recordati Industria Chimica e Farmaceutica SpA
Cash Equivalents
Recordati Industria Chimica e Farmaceutica SpA
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
Cash Equivalents
€200.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
6%
|
|
|
Newron Pharmaceuticals SpA
SIX:NWRN
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Pierrel SpA
MIL:PRL
|
Cash Equivalents
€4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
33%
|
CAGR 10-Years
16%
|
|
|
Friulchem SpA
MIL:FCM
|
Cash Equivalents
€4.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shedir Pharma Srl Unipersonale
MIL:SHE
|
Cash Equivalents
€1.1m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
|
Recordati Industria Chimica e Farmaceutica SpA
Glance View
Recordati Industria Chimica e Farmaceutica SpA is a well-established pharmaceutical company based in Italy, renowned for its commitment to innovation and high-quality healthcare solutions. Founded in 1926, Recordati has evolved from a small family business into a global player in the pharmaceutical industry, focusing on the development and marketing of specialty pharmaceuticals, particularly for rare diseases and niche therapeutic areas. With a strategic emphasis on expanding its portfolio through research and development as well as targeted acquisitions, the company showcases a strong pipeline of products designed to address unmet medical needs, thus positioning itself as a crucial player in the evolving healthcare landscape. For investors, Recordati presents a compelling opportunity rooted in its steady growth trajectory and solid fiscal health. The company boasts a diverse revenue stream generated from its proprietary medicines, coupled with a robust international presence that spans over 150 countries. With ongoing efforts to strengthen its research capabilities and expand into emerging markets, Recordati is strategically positioned to capitalize on the rising global demand for specialized healthcare products. Its proven track record of performance, paired with a focus on sustainability and corporate responsibility, further enhances its attractiveness as a long-term investment, aligning well with the values of investors seeking ethical and financially sound opportunities in the pharmaceutical sector.
See Also
What is Recordati Industria Chimica e Farmaceutica SpA's Cash Equivalents?
Cash Equivalents
200.6m
EUR
Based on the financial report for Jun 30, 2024, Recordati Industria Chimica e Farmaceutica SpA's Cash Equivalents amounts to 200.6m EUR.
What is Recordati Industria Chimica e Farmaceutica SpA's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
6%
Over the last year, the Cash Equivalents growth was -62%. The average annual Cash Equivalents growth rates for Recordati Industria Chimica e Farmaceutica SpA have been -10% over the past three years , 14% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
